Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Looking for ways to earn fast with minimal effort? Discover effective strategies to boost your income without overwhelming yourself.
11,858 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A high-profile creator faced a dramatic revenue tumble after backlash, underscoring how follower counts don’t guarant...
When a legendary investor shifts big positions, traders sit up. This piece breaks down what it could mean that billio...
Bitcoin is trapped in a converging triangle as traders brace for a sharp breakout. A decisive move beyond key levels ...
As AI accelerates, a different kind of winner emerges. This article shows why data-center REITs, not flashy chips, ma...
When a beloved tech stock slips after earnings, investors ask one question: should stock? This guide breaks down how ...
Hims Hers continues to blend telehealth with consumer products. This guide breaks down the key metrics from the earni...
DigitalOcean beats Q4 2025 expectations as AI-driven ARR surges to $120 million, lifting revenue to $242 million and ...
NuScale Power stock surged to a record before succumbing to a mix of policy, funding, and project risks. This guide b...
Palo Alto Networks is trading lower as acquisition costs press on near-term guidance, even as AI security bets throug...
Investors are torn over a high-growth AI stock. This article breaks down the split, lays out the bull case, and shows...
As Agilent prepares to reveal its Q1 2026 results, investors want clarity on growth signals and margins. This guide b...